Topic Archives: Unity Biotechnology (UBX)

I’ve seen this ad circulated so many times, with adjusting deadlines, that I didn’t realize I hadn’t specifically covered this pitch for my favorite readers… at least, not in its current iteration with a new company in that “Day Zero” position. “Day Zero” is now trumpeted as being December 4, but not long ago it […]

A version of this article was originally published on October 21, 2019, but the ad continues to circulate and generate new questions so we have updated it to address any changes over the past six months. Hard to believe that the major publishers didn’t already have something called The Penny Stock Letter, but this is […]

For some reason, the investment newsletter audience (and their publishers) find “anti-aging” pitches quite appealing… maybe it’s because so many of us are reaching those “golden years” and wondering how to extend them without pain or poverty. I’m not quite in the “core” demographic yet at 49, but I’ve got the knees and hips of […]

Comments

  • Avatar

    UBX...

  • Avatar

    Any research on Unity Biotechnology (UBX) for eye disorders and blindness?...

  • Avatar

    Technology & Opportunity currently has UBX as a hold and is listed as one of their higher risk holdings . They had it l...

  • Avatar

    UBX is what I can see for Unity Biotechnology, looking at their investors presentation, looks promising, but maybe will ...

  • Avatar

    UBX Focuses on reversing age-related diseases - End of Aging...

  • Avatar

    Apparently the Youth Pill UBX will give you gray hair as you watch its gyrations! BUY VNNHF and PSTH and make some R...

  • Travis Johnson, Stock Gumshoe

    Not sure if you meant to ask a question, but Unity Biotechnology has been teased many times over the past year or so... ...

  • Avatar

    It's been a while since I've crept on this board, but a wonderfully entertaining writeup as usual Travis... $UBX is inde...

  • Avatar

    Out of curiosity I took a peek at the chart for UBX. Didn't have the crater in March that much of the market did, but q...

  • Travis Johnson, Stock Gumshoe

    Yep, TORC and UBX have been the two most popular "anti aging" pitches in the past couple years....

  • Avatar

    don't buy UBX until it hits $2.78 again....

  • Avatar

    Just wanted to say Jason Stutman's Tech & Oppurtunity rates UBX as a buy @ ...

  • Avatar

    How many 'Day Zeros' are there going to be? Maybe he should rename them as 'Daily Disappointments' or 'Day Dump'. I alm...

  • Avatar

    OMG! Why did you have to mention and remind me about UBX? That is just so mean. And I'm new here! UBX was recommende...

  • Avatar

    I only learned about the Penny Stock letter thing today and after researching I came across your article, which I immens...

  • Avatar

    Many of you may have already seen or heard about 'The World's First 'UNBEATABLE' Stock-Picking System' brought to you by...

  • Avatar

    That above is for the lawyers. But his readers lost a large amount of money this AM. Hie teasing to the moon for UBX ju...

  • Avatar

    I been trading for about two months and UBX was one of the first stocks i bought, i have only 35 under $8, I truly belie...

  • Avatar

    I think the stock is way overpriced. I’ve been following another early stage biotech which has a promising unique trea...

  • Avatar

    UBX looks like it is back, with the earth-shaking announcement due May 8....

  • Travis Johnson, Stock Gumshoe

    There were a couple similar teasers that match up with this late last year, my most recent piece is here: https://www.st...

  • Avatar

    Hi Travis, Thank you for the article! I enjoyed reading it. Regarding UBX, I would NOT buy it. I would recommend Gumsho...

  • Avatar

    Sorry for my bad english. There is a drug that my aunt developed back in Soviet times. She tested it on her friend, who ...

  • Travis Johnson, Stock Gumshoe
  • Avatar

    Just opened an email: Urgent Medical Breakthrough: Tiny Company’s Clinical Studies Break the Laws of Human Nature, Se...

  • Avatar
  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info